Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Dermapharm Shareholders Equity (Quarterly) : 613.63M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 613.63M |
| March 31, 2026 | 851.32M |
| December 31, 2025 | 815.51M |
| September 30, 2025 | 762.84M |
| June 30, 2025 | 713.99M |
| March 31, 2025 | 689.77M |
| December 31, 2024 | 625.88M |
| September 30, 2024 | 651.44M |
| June 30, 2024 | 591.13M |
| March 31, 2024 | 628.47M |
| December 31, 2023 | 595.64M |
| September 30, 2023 | 577.96M |
| June 30, 2023 | 568.63M |
| March 31, 2023 | 630.75M |
| December 31, 2022 | 567.34M |
| September 30, 2022 | 493.61M |
| June 30, 2022 | 473.58M |
| March 31, 2022 | 594.25M |
| Date | Value |
|---|---|
| December 31, 2021 | 565.55M |
| September 30, 2021 | 490.47M |
| June 30, 2021 | 429.90M |
| March 31, 2021 | 421.14M |
| December 31, 2020 | 393.94M |
| September 30, 2020 | 348.57M |
| June 30, 2020 | 308.87M |
| March 31, 2020 | 334.74M |
| December 31, 2019 | 312.78M |
| September 30, 2019 | 283.40M |
| June 30, 2019 | 287.86M |
| March 31, 2019 | 307.52M |
| December 31, 2018 | 288.59M |
| September 30, 2018 | 278.82M |
| June 30, 2018 | 253.74M |
| March 31, 2018 | 246.07M |
| December 31, 2017 | 88.48M |
| September 30, 2017 | 82.15M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Avadel Pharmaceuticals Plc | 98.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.564B |
| Total Liabilities (Quarterly) | 1.954B |
| Debt to Equity Ratio | 2.178 |
| Current Ratio | 1.712 |
| Net Debt Paydown Yield | -1.99% |